CLINICAL_TRIALS
trial_result
· 2021-05-18
Clinical Trial Update: Sublingual Fentanyl for the Management of Breakthrough Pain [Phase 2]
Summary
Phase 2 clinical trial of sublingual fentanyl for breakthrough pain in advanced cancers was terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancers | Phase 2 | Status: TERMINATED | Results posted: 2021-05-18